Authored By: Sarah
09 Feb 2023

In-vitro Diagnostics Market Share, Segments, Trends, Growth, and Geography- Analysis, and Forecast 2022-2026

The in-vitro diagnostics market share is forecast to reach USD 33.16 billion, after growing at a CAGR of 6.89% during 2022-2026. The increasing geriatric population with chronic and infectious diseases is analyzed to boost the addictions therapeutics market growth. Moreover, technological advances in in-vitro diagnostics is the major trend enhancing the overall market demand for in-vitro diagnostics during the forecast period.   

Get a snapshot of the in-vitro diagnostics market analysis: Unlock the Sample Report 

Browse Technavio's 145-page report and in-depth TOC on "In-vitro Diagnostics Market by Technology (immunoassay, molecular diagnostics, clinical chemistry, hematology, and others) and geography (North America, Europe, Asia, and the Rest of the World (ROW)).

View detailed Table of Contents Here: https://www.technavio.com/report/in-vitro-diagnostics-market-industry-analysis

In-vitro Diagnostics Market Share, Segments, Trends, Growth, and Geography- Analysis, and Forecast 2022-2026

Technology: 

  • Immunoassay: The IVD market share growth by the immunoassay segment will be significant during the forecast period.

  • Molecular diagnostics

  • Clinical chemistry

  • Hematology

  • Others

Geography: 

  • North America: The increased insurance coverage will facilitate the in-vitro diagnostics (IVD) market growth in North America over the forecast period. 35% of the market’s growth will originate from North America during the forecast period. 

  • Europe

  • Asia

  • Rest of the World (ROW) 

Key Takeaways: 

  • The in-vitro diagnostics market size will witness a YOY Growth Rate of 6.03% in 2022.  

  • The stringent regulatory guidelines will be a major challenge for the in-vitro diagnostics market during the forecast period. 

  • Major key in-vitro diagnostics market players include Abbott Laboratories, Agilent Technologies Inc., ARKRAY Inc., Becton Dickinson and Co., BGI Group, Bio Rad Laboratories Inc., bioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Grifols SA, Illumina Inc., Ortho Clinical Diagnostics plc, QIAGEN NV, Quest Diagnostics Inc., Siemens AG, Sysmex Corp, and Thermo Fisher Scientific Inc. 

  • The report illustrates the lifecycle of the market, focusing on the adoption rates of the major regions such as the North America, Europe, Asia, and the Rest of the World (ROW). 

Download the PDF sample report for highlights on the market size, growth momentum, regional growth opportunities, vendor analysis, and other factors influencing the market growth. 

Key data covered in the In-vitro Diagnostics Market report 

  • Precise market size estimation during the forecast period 2022-2026.  

  • CAGR of the in-vitro diagnostics market forecast during 2022-2026.  

  • Market-level data on units, average selling prices, and values of the in-vitro diagnostics market share.  

  • Prediction of the upcoming trends, drivers, and factors that challenge the growth of the in-vitro diagnostics market.  

  • In-vitro diagnostics industry growth across North America, Europe, Asia, and the Rest of the World (ROW). 

Read News Read Less
Interested in this report?
Get your sample now!
Technavio
Document